Inventor · disambiguated record
Michael C. Chen
Also filed as: CHEN MICHAEL · CHEN MICHAEL C · CHEN MICHAEL CHUN HAO
22 granted patents·39 pending applications·158 citations·filing 1980–2025
93Inventor score
Files withNUCLERA LTD16NUCLERA NUCLEICS LTD13ACHELOIS BIOPHARMA INC9PURETECH LYT 100 INC7CYTOARM CO LTD4
Top patents by PatentIndex Score
61 records- 0190US11807887B2Compositions and methods related to nucleic acid synthesisNUCLERA LTD·Filed 2021·Granted Nov 7, 2023·1 cites·11 claims
- 0288US10745727B2Compositions and methods related to nucleic acid synthesisNUCLERA NUCLEICS LTD·Filed 2016·Granted Aug 18, 2020·3 cites·17 claims
- 0387US11806715B2Method of electrowettingNUCLERA LTD·Filed 2022·Granted Nov 7, 2023·1 cites·12 claims
- 0486US12129501B2Polymer synthesis using electrowetting devicesNUCLERA LTD·Filed 2022·Granted Oct 29, 2024·1 cites·10 claims
- 0585US7585669B2Compositions and methods for treating or preventing pneumococcal infectionSYNERGY AMERICA INC·Filed 2007·Granted Sep 8, 2009·10 cites·18 claims
- 0684US4370417ARecombinant deoxyribonucleic acid which codes for plasminogen activatorABBOTT LAB·Filed 1980·Granted Jan 25, 1983·34 cites·25 claims
- 0783US11236377B2Compositions and methods related to nucleic acid synthesisNUCLERA NUCLEICS LTD·Filed 2020·Granted Feb 1, 2022·1 cites·17 claims
- 0883US2024084350A1Compositions and Methods Related to Nucleic Acid SynthesisNUCLERA LTD·Filed 2023·Application pending·0 cites
- 0982US7217791B2Compositions and methods for treating or preventing pneumococcal infectionSYNERGY AMERICA INC·Filed 2003·Granted May 15, 2007·21 cites·34 claims
- 1081US11993800B2Use of terminal transferase enzyme in nucleic acid synthesisNUCLERA LTD·Filed 2018·Granted May 28, 2024·1 cites·17 claims
- 1181US11505815B2Compositions and methods related to non-templated enzymatic nucleic acid synthesisNUCLERA NUCLEICS LTD·Filed 2018·Granted Nov 22, 2022·2 cites·6 claims
- 1281US11466301B2Nucleotide triphosphate immobilised on a support and their use in nucleic acid synthesisNUCLERA NUCLEICS LTD·Filed 2018·Granted Oct 11, 2022·2 cites·19 claims
- 1377US2024301458A1Use of Terminal Transferase Enzyme in Nucleic Acid SynthesisNUCLERA LTD·Filed 2024·Application pending·0 cites
- 1475US5422267AIndustrial yeast comprising an integrated glucoamylase geneYOCUM ROBERT R·Filed 1990·Granted Jun 6, 1995·70 cites·56 claims
- 1572US2025114341A1Methods of treating idiopathic pulmonary fibrosis with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 1668US2025114340A1Methods of treating interstitial lung diseases and other fibrotic-mediated pulmonary diseases and disorders with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 1766US2025375431A1Methods of treating idiopathic pulmonary fibrosis with deupirfenidonePURE TECH LYT 100 INC·Filed 2025·Application pending·0 cites
- 1865US2025025450A1Methods of treating interstitial lung diseases and other fibrotic-mediated pulmonary diseases and disorders with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 1965US2025382608A1Linear nucleic acid expression constructsNUCLERA LTD·Filed 2023·Application pending·0 cites
- 2064US2020093810A1Deuterium-enriched pirfenidone and methods of use thereofPureTech Health LLC·Filed 2019·Application pending·0 cites
- 2163US2023167477A1Protein PurificationNUCLERA NUCLEICS LTD·Filed 2022·Application pending·0 cites
- 2263US2023255946A1Methods of treating diseases and disorders with deupirfenidonePURE TECH LYT 100 INC·Filed 2023·Application pending·0 cites
- 2363US2025146041A1Methods for cell free protein synthesis and post translational modification of the expressed proteinsNUCLERA LTD·Filed 2023·Application pending·0 cites
- 2463US2024280580A1Protein aggregation assaysNUCLERA LTD·Filed 2024·Application pending·0 cites
- 2562US2021261998A1Compositions and methods related to nucleic acid preparationNUCLERA NUCLEICS LTD·Filed 2021·Application pending·0 cites
- 2662US2021205283A1Deuterium-enriched pirfenidone and methods of use thereofPURETECH LYT 100 INC·Filed 2021·Application pending·0 cites
- 2761US2023040415A1Methods of treating lymphedema with deupirfenidonePURETECH LYT 100 INC·Filed 2022·Application pending·0 cites
- 2860US11453705B2Multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2021·Granted Sep 27, 2022·0 cites·16 claims
- 2960US2024358690A1Methods of treating idiopathic pulmonary fibrosis with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 3060US2025288662A1Multivalent display on enveloped particles with human oligomerization domainsACHELOIS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3158US12116600B2Modified terminal deoxynucleotidyl transferase (TdT) enzymesNUCLERA LTD·Filed 2021·Granted Oct 15, 2024·0 cites·16 claims
- 3258US2022332769A1Multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3357US2024391979A1Hepatitis b virus antivirus (hbv-antivirus) compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3456US2024359181A1Methods and compositions for improved biomolecule assays on digital microfluidic devicesNUCLERA LTD·Filed 2022·Application pending·0 cites
- 3555US11821018B2Methods for cell-free protein expressionNUCLERA LTD·Filed 2022·Granted Nov 21, 2023·0 cites·13 claims
- 3655US2024139251A1Antigen-specific t cells, methods of producing the same, and uses thereofCYTOARM CO LTD·Filed 2023·Application pending·0 cites
- 3755US2025289867A1Multivalent particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3854US2023357730A1Modified Terminal Deoxynucleotidyl Transferase (TdT) EnzymesNUCLERA LTD·Filed 2021·Application pending·0 cites
- 3954US2024398902A1Multivalent interferon particles compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4053US2023129866A1Methods of treating respiratory disease with deupirfenidonePURETECH LYT 100 INC·Filed 2021·Application pending·0 cites
- 4152US2023151046A15-position modified pyrimidinesNUCLERA NUCLEICS LTD·Filed 2021·Application pending·0 cites
- 4252US2024044878A1Monitoring of in vitro protein synthesisNUCLERA LTD·Filed 2021·Application pending·0 cites
- 4351US2022259632A1Method of oligonucleotide synthesisNUCLERA NUCLEICS LTD·Filed 2020·Application pending·0 cites
- 4450US2024360181A1Compositions and methods for multivalent surface display on enveloped particlesACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4550US2025127894A1Process for producing armed immune cellsCYTOARM CO LTD·Filed 2022·Application pending·0 cites
- 4649US12312611B2Modified terminal deoxynucleotidyl transferase (TdT) enzymesNUCLERA LTD·Filed 2020·Granted May 27, 2025·0 cites·17 claims
- 4749US2024254203A1Antibody-based antivirus compositions and methods of useACHELOIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4848US11623940B2Methods of nucleic acid synthesis comprising polyphosphate containing speciesNUCLERA NUCLEICS LTD·Filed 2018·Granted Apr 11, 2023·0 cites·18 claims
- 4948US11571476B2Anti-tumor/anti-tumor associated fibroblast/anti-hapten trispecific antibodies and use thereofUNIV TAIPEI MEDICAL·Filed 2017·Granted Feb 7, 2023·0 cites·12 claims
- 5048US11320427B2Tandemly repeated antibody-binding protein and its applicationsUNIV TAIPEI MEDICAL·Filed 2017·Granted May 3, 2022·0 cites·11 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael C. Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →